ECLAMPSIA

MATERNAL AND PERINATAL MORTALITY AT BMC COMPLEX QUETTA

Abstract

Objective: To evaluate incidence, morbidity and
mortality associated with Eclampsia. Design: Prospective study of 98 cases of eclampsia. Setting: department
of obstetrics and gynaecology unit II Bolan Medical Collage Complex Quetta. Patients: 98 cases were admitted
with eclampsia during two years and six months period from 1st June 2001 to December 2003. Results: Total
no of admissions were 6952. 98 patients presented with eclampsia making a frequency of 1.40%. Of these 98
cases of eclampsia 58 % were primigravidas, mean age of eclamptic patients was 34 years. Gestational age at
admission was less than 35 weeks in 80(78.4%) cases. 54(55%) patients had intrapartum eclampsia.64 (66.7%)
patients received diazepam and rest received Magnesium sulphate as anticonvulsant. Caesarean section was done
in 10 (11.49%) cases rest delivered vaginally. Fetal loss was seen in 72(82.75%) patients, while 7(7.14%) mothers
died of eclampsia. Conclusion: Maternal and perinatal mortality and morbidity is very high in eclemptic
patients. Magnesium sulphate is good anticonvulsant, helpful in reducing maternal morbidity and mortality
considerably. Good antenatal practices, maternal education and awareness, provision of better health facilities
and their utilization will definitely improve maternal and fetal outcome.